John E. Conte
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy
Papers in ⓘ
- Pharmacology 38
- Antibiotics Pharmacokinetics and Efficacy 33
- Drug-Induced Adverse Reactions 6
- Epidemiology 37
- Pneumocystis jirovecii pneumonia detection and treatment 21
- Pneumonia and Respiratory Infections 19
- Co-authors
- Jeffrey A. Golden (22 shared papers)Elisabeth Zurlinden (19 shared papers)Juliana Kipps (9 shared papers)E T Lin (9 shared papers)E. Zurlinden (7 shared papers)Sheila Duncan (6 shared papers)Richard V. Aghababian (1 shared paper)Mary Grace Kelly (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (22 papers)Clinical Infectious Diseases (5 papers)Annals of Internal Medicine (4 papers)The American Journal of Medicine (4 papers)International Journal of Antimicrobial Agents (4 papers)
- Partner nations
- United StatesFranceSweden
In The Last Decade
John E. Conte
75 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 119
- Molecular Medicine 424
- Pharmacology 880
- Infectious Diseases 916
- Applied Microbiology and Biotechnology 73
- Epidemiology 1.2k
Countries citing papers authored by John E. Conte
This map shows the geographic impact of John E. Conte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Conte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Conte more than expected).
Fields of papers citing papers by John E. Conte
This network shows the impact of papers produced by John E. Conte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Conte. The network helps show where John E. Conte may publish in the future.
Co-authors
The 25 scholars most cited alongside John E. Conte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 230 | |
| 2 | 2005 | 150 | |
| 3 | 1972 | 133 | |
| 4 | 1996 | 129 | |
| 5 | 1987 | 94 | |
| 6 | 1995 | 94 | |
| 7 | 1988 | 88 | |
| 8 | 1980 | 87 | |
| 9 | 1983 | 79 | |
| 10 | 2008 | 67 | |
| 11 | 1990 | 66 | |
| 12 | 1986 | 66 | |
| 13 | 1992 | 61 | |
| 14 | 1988 | 59 | |
| 15 | 2002 | 55 | |
| 16 | 2001 | 50 | |
| 17 | 2004 | 46 | |
| 18 | 2005 | 46 | |
| 19 | 1999 | 45 | |
| 20 | 2006 | 37 |
About John E. Conte
John E. Conte is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Molecular Medicine and Analytical Chemistry, having authored 75 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (33 papers), Pneumocystis jirovecii pneumonia detection and treatment (21 papers), Pneumonia and Respiratory Infections (19 papers), Antibiotic Resistance in Bacteria (16 papers), Analytical Methods in Pharmaceuticals (9 papers), Antifungal resistance and susceptibility (8 papers), Drug-Induced Adverse Reactions (6 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). The work is most often cited by research in Molecular Medicine (424 citations), Pharmacology (880 citations), Infectious Diseases (916 citations), Applied Microbiology and Biotechnology (73 citations) and Epidemiology (1.2k citations). John E. Conte has collaborated with scholars based in United States, France and Sweden. Frequent co-authors include Jeffrey A. Golden, Elisabeth Zurlinden, Juliana Kipps, E T Lin, E. Zurlinden, Sheila Duncan, Richard V. Aghababian, Mary Grace Kelly, Emil T. Lin and Merle A. Sande. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Annals of Internal Medicine, The American Journal of Medicine and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.